A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD

NCT02276222 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1087

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: SUN-101 50 mcg BID eFlow (CS) nebulizer
DRUG: Spiriva® 18 mcg QD Handihaler

Sponsor

Sunovion Respiratory Development Inc.